PLoS ONE, 2010 · DOI: 10.1371/journal.pone.0011852 · Published: July 29, 2010
This research explores using human motor neuron progenitors (hMNPs) derived from human embryonic stem cells (hESCs) to treat spinal cord injuries (SCI) in rats. The study found that transplanting hMNPs into injured spinal cords can promote the survival of existing neurons and enhance nerve fiber growth, leading to improved motor function. However, the environment of the injured spinal cord can hinder the full maturation of transplanted cells, suggesting that further strategies are needed to support their development into fully functional motor neurons.
hMNP transplantation shows promise as a therapeutic strategy for SCI by providing neurotrophic support and promoting neuronal survival.
Further research is needed to develop strategies that promote hMNP maturation and integration within the injured spinal cord environment.
These findings support further investigation into the clinical translation of hMNP-based therapies for SCI patients.